Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines

AIDS

Volumn 28, Issue SUPPL. 2, 2014, Pages

  Nelson, Lisa J ^a   Beusenberg, Michael ^a   Habiyambere, Vincent ^a   Shaffer, Nathan ^a   Vitoria, Marco A ^a   Montero, Raul Gonzalez ^a   Easterbrook, Philippa J ^a   Doherty, Meg C ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

antiretroviral therapy; guidelines; HIV; policies; treatment; WHO

Indexed keywords

EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; TENOFOVIR; ANTIRETROVIRUS AGENT;

ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DESCRIPTIVE RESEARCH; DRUG TREATMENT FAILURE; HEALTH CARE DELIVERY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUBERCULOSIS; VIRUS LOAD; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; CHILD; FEMALE; HEALTH; HEALTH CARE POLICY; HIV INFECTIONS; MALE; PREGNANCY; PREVENTION AND CONTROL; RISK FACTOR; TRANSMISSION; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; FEMALE; GLOBAL HEALTH; HEALTH POLICY; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; RISK FACTORS; WORLD HEALTH ORGANIZATION;

EID: 84901466384     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000239     Document Type: Article

References (11)

1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013, www.who.int/hiv/pub/guidelines/arv2013. [Accessed 26 January 2014]
2. Vitoria M, Vella S, Ford N. Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges. Curr Opin HIV AIDS 2013; 8:12-18.
3. World HealthOrganization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: programmatic update. Geneva: World Health Organization; 2012, http://whqlibdoc.who.int/publications/2010/ 9789241599818-eng.pdf. [Accessed 26 January 2014]
4. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. [2010 revision]. Geneva: World Health Organization; 2010, http://whqlibdoc.who.int/ publi cations/2010/9789241599764-eng.pdf. [Accessed 26 January 2014]
5. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach. [2010 revision]. Geneva: World Health Organization; 2010, http://whqlibdoc.who.int/publications/2010/ 9789241599818-eng.pdf. [Accessed 26 January 2014]
6. World Health Organization. Guidance on couples HIV testing and counseling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach. Geneva: World Health Organization; 2012.
7. World Bank. http://data.worldbank.org/about/country-classifications.
8. World Health Organization. AMDS survey on ARV use and laboratory use and implementation of WHO-related guidelines. 2013.
9. Antiretroviral Treatment in the Spotlight: A Public Health Analysis in Latin America and the Caribbean 2013. Washington, DC: PAHO; 2013.
10. World health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. [2010 revision]. Geneva: World health Organization; 2010, http://whqlibdoc. who.int/publications/2010/9789241599801-eng.pdf. [Accessed 26 January 2014]
11. Gupta S, Granich R, Suthar AB, Smyth C, Baggaley R, Sculier D, et al. Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples. J Acquir Immune Defic Syndr 2013; 62:e87-e97.